ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	12/41	134/7206	5.19220682753e-12
ko04668	TNF signaling pathway	10/41	120/7206	8.15580916871e-10
ko04630	Jak-STAT signaling pathway	9/41	132/7206	3.76885539358e-08
ko04210	Apoptosis	8/41	180/7206	6.125153782e-06
ko04657	IL-17 signaling pathway	6/41	87/7206	8.33955610353e-06
ko04917	Prolactin signaling pathway	6/41	87/7206	8.33955610353e-06
ko05167	Kaposi's sarcoma-associated herpesvirus infection	8/41	191/7206	9.49406060288e-06
ko04620	Toll-like receptor signaling pathway	6/41	100/7206	1.86435129797e-05
ko05160	Hepatitis C	7/41	153/7206	2.07967706898e-05
ko05164	Influenza A	7/41	167/7206	3.66376565965e-05
ko04660	T cell receptor signaling pathway	6/41	124/7206	6.31605984844e-05
ko05168	Herpes simplex infection	7/41	182/7206	6.35062746627e-05
ko04920	Adipocytokine signaling pathway	5/41	89/7206	0.000135482636572
ko05132	Salmonella infection	5/41	98/7206	0.000213494853565
ko05161	Hepatitis B	6/41	173/7206	0.000392885524515
ko05162	Measles	5/41	120/7206	0.000546598062853
ko05142	Chagas disease (American trypanosomiasis)	5/41	130/7206	0.000787447478667
ko05166	HTLV-I infection	7/41	292/7206	0.00114595404369
ko05133	Pertussis	4/41	87/7206	0.00142793458036
ko05120	Epithelial cell signaling in Helicobacter pylori infection	4/41	92/7206	0.00175614954312
ko04621	NOD-like receptor signaling pathway	5/41	157/7206	0.00183229561356
ko04659	Th17 cell differentiation	4/41	106/7206	0.00294838832016
ko05206	MicroRNAs in cancer	5/41	177/7206	0.00309287830579
ko05321	Inflammatory bowel disease (IBD)	3/41	56/7206	0.00384526266506
ko01522	Endocrine resistance	4/41	124/7206	0.00517300846919
ko05145	Toxoplasmosis	4/41	126/7206	0.00547434048778
ko04915	Estrogen signaling pathway	4/41	131/7206	0.00627877078851
ko04933	AGE-RAGE signaling pathway in diabetic complications	4/41	135/7206	0.00697647320842
ko04931	Insulin resistance	4/41	137/7206	0.0073438961449
ko05140	Leishmaniasis	3/41	75/7206	0.00869398627363
ko04010	MAPK signaling pathway	6/41	321/7206	0.00897309321826
ko05131	Shigellosis	3/41	82/7206	0.0110940741204
ko04662	B cell receptor signaling pathway	3/41	88/7206	0.0134280847324
ko05323	Rheumatoid arthritis	3/41	89/7206	0.0138423126786
ko05418	Fluid shear stress and atherosclerosis	4/41	173/7206	0.0162772518294
ko04658	Th1 and Th2 cell differentiation	3/41	96/7206	0.0169460927224
ko04064	NF-kappa B signaling pathway	3/41	96/7206	0.0169460927224
ko04217	Necroptosis	4/41	178/7206	0.0178928872769
ko04932	Non-alcoholic fatty liver disease (NAFLD)	4/41	182/7206	0.0192555137479
ko05203	Viral carcinogenesis	5/41	277/7206	0.0195581766684
ko04623	Cytosolic DNA-sensing pathway	2/41	41/7206	0.0225166575059
ko04060	Cytokine-cytokine receptor interaction	4/41	191/7206	0.0225537624407
ko05169	Epstein-Barr virus infection	4/41	206/7206	0.0287837810781
ko05219	Bladder cancer	2/41	48/7206	0.0302116026169
ko04624	Toll and Imd signaling pathway	2/41	49/7206	0.0313854121785
ko04930	Type II diabetes mellitus	2/41	54/7206	0.0375187378936
ko05231	Choline metabolism in cancer	3/41	134/7206	0.0401165597982
ko04622	RIG-I-like receptor signaling pathway	2/41	62/7206	0.0481938696093
ko05221	Acute myeloid leukemia	2/41	63/7206	0.0495982841964